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Should you restrict your  
cardiac patient from driving? 
That	depends,	of	course,	on	your	patient’s	
particular	condition,	but	your	decision	
can	be	guided	by	various	cardiovascular	
society	consensus	conferences,	such	as	
the	one	from	the	Canadian	Cardiovascular	
society	(Table),	since	no	evidence-based	
guidelines	exist.	It	seems	sensible	to	say,	
though,	that	impairment	of	consciousness	
associated	with	any	heart	disease	needs	
further	evaluation,	with	a	complete	
restriction	of	driving	for	at	least	6	months	
(strength	of	recommendation	[sor]:	C,	
based	on	expert	opinion	and	extrapolation	
from	observational	studies).
Helpful guide stratifies risk 
This	review	points	out	the	lack	of	
evidence	for	a	common	clinical	problem.	
evidence	is	scant,	but	the	Table	helps	
the	busy	clinician	stratify	risks	for	different	
types	of	heart	disease	and	provides	
some	rational	basis	for	the	duration	
of	restrictions.	The	existing	expert	
consensus	guidelines	are	sensible	and	
useful	when	discussing	this	important	
issue	with	patients	and	their	families	after	
diagnosis	of	heart	disease.	However,	to	
be	quite	frank,	when	I	am	driving	I	am	
more	worried	about	the	teenager	on	a	cell	
phone	behind	the	wheel	of	an	suv	than	
my	grandmother	with	an	ICD.
Drew Malloy, MD
university	of	California	santa	Cruz	
student	Health	service
z evidence summary
Our search identified no randomized 
controlled trials, no systematic reviews, 
6 observational studies, and 3 con-
sensus panel guidelines on risks from 
driving and cardiovascular disease. 
No studies deal specifically with coro-
nary artery disease, congestive heart 
failure, or valvular heart disease and 
the risk of motor vehicle crashes for 
patients with these conditions. A popu-
lation-based case control study of 5204 
male drivers ages 45 to 70 in Quebec 
found no increased risk of crash for 
drivers with unspecified cardiovascular 
disease.1
Car accidents among  
ICD patients are low
The most studied patients are those 
with life-threatening ventricular 
arrhythmias—particularly those with 
implantable cardioverter-defibrillators 
(ICDs). Based on observational stud-
ies of patients and their physicians, 
patients with ventricular arrhythmias 
treated with ICDs do not have an in-
creased risk of motor vehicle crashes.2–4 
The largest of the studies2 prospec-
tively and anonymously surveyed 627 
patients from the Antiarrhythmics vs 
Implantable Defibrillators Trial. Dur-
ing follow-up, 2% of patients had a 
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Evidence-based answer
Clinical commentary
fast track
Patients should 
wait 6 months  
after ventricular 
fibrillation or  
unstable ventricular 
tachycardia before 
they resume  
driving
—Canadian 
Cardiovascular Society
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syncopal episode while driving, and 
11% had dizziness or palpitations that 
required stopping the vehicle. 
Of the 55 car crashes that occurred 
during 1619 patient-years after resump-
tion of driving, 11% were preceded by a 
possible symptom of arrhythmia 
(0.4% per patient per year). The annual 
incidence of car accidents for patients 
with an ICD was 3.4% per patient-year. 
This is substantially lower than the 
7.1% rate among the general driving 
population in the US. 
Recommendations from others
Expert panel guidelines regarding fit-
ness to drive for patients with heart 
disease are available from the Cana-
dian Cardiovascular Society (CCS),5 
the European Society of Cardiology, 
the American Heart Association, the 
North American Society of Pacing and 
Physiology,6 and the Cardiac Society of 
Australia and New Zealand.7 The 2004 
CCS guidelines are the most recent and 
include a “Risk of Harm” formula that 
attempts to assign a quantitative level of 
risk to drivers with heart disease. These 
guidelines appear sensible but are not 
evidence-based (Table).  n
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Should your heart patient get behind the wheel? 
a helpful guide
tablE
CondiTions TimE To rEsumE driving
Coronary artery disease
Coronary	bypass	graft	 1	month	after	discharge
sT	elevation	myocardial	infarction	 1	month	after	discharge
unstable	angina	 		
					–	PCI	during	hospital	stay	 48	hours	after	PCI	
					–	PCI	not	done	during	hospital	stay	 7	days	after	discharge
ventricular arrhythmias
Non-sustained	vT	with		
no	loss	of	consciousness	 	No	restriction
vF	or	unstable	vT	 	6	months	after	event
implantable cardioverter defibrillator
For	vF	or	vT	with	decreased		
level	of	consciousness	 	6	months	after	event
rhythm disturbances
atrial	flutter	(without	impaired		
level	of	consciousness)	 	No	restriction
supraventricular	tachycardia	 	No	restriction
atrial	fibrillation	 	No	restriction
Heart block
First-	and	second-degree		
atrioventricular	block,	mobitz	Type	1		
(without	impairment	of	consciousness)	 	No	restriction
second-degree	atrioventricular	block,		
mobitz	Type	II	 	No	driving
Permanent pacemaker
all	patients	 1	week	after	implant;		
	 normal	pacer	function;		
	 no	impaired	level	of	consciousness
Congestive heart failure
NyHa	Classes	I–III	 	No	restriction
NyHa	Classes	Iv	 	No	driving
adapted	from	Canadian	Cardiovascular	society	Consensus	Conference	2003.5
PCI,	percutaneous	coronary	intervention;	vF,	ventricular	fibrillation;		
vT,	ventricular	tachycardia;	NyHa,	New	york	Heart	association
